No longer a niche hobby, the digital entertainment ecosystem exploded in mainstream popularity over the years, thus incentivizing investments in gaming growth stocks. According to the World Economic F
LAS VEGAS--(BUSINESS WIRE)--PLAYSTUDIOS, Inc. (Nasdaq: MYPS) (“PLAYSTUDIOS” or the “Company”), the creator of the playAWARDS loyalty platform and an award-winning developer of free-to-play mob
The Playstudios loyalty program is a key to everything. The key to MYPS upside is margin expansion.

Playstudios: No Brainer In 2023

02:20am, Friday, 25'th Nov 2022
Playstudios is poised to ride a better mobile gaming market higher in 2023. The company recently closed the Brainium deal to boost revenues and loyalty program members.
PLAYSTUDIOS, Inc. (NASDAQ:MYPS ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Samir Jain - Head of IR and Treasury Andrew Pascal - Co-Founder, Chairman and CEO Sco
PLAYSTUDIOS, Inc. (MYPS) delivered earnings and revenue surprises of 0% and 6.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PLAYSTUDIOS, Inc. (MYPS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Playstudios: Massively Undervalued

02:54am, Sunday, 14'th Aug 2022
Playstudios has been hit in the short term by changing behavioral trends. Playstudios retains its loyal customer base.
PLAYSTUDIOS, Inc. (NASDAQ:MYPS ) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Joel Agena - Vice President, Legal Counsel Andrew Pascal - Co Founder, Chairman and Chi
Playstudios, a publicly-traded mobile gaming platform and developer, is venturing into the web3 world with a new blockchain division and investment fund.
LAS VEGAS--(BUSINESS WIRE)--PLAYSTUDIOS, Inc. (Nasdaq: MYPS) (“PLAYSTUDIOS” or the “Company”), an award-winning developer of free-to-play casual mobile and social games that offer real-world r
Upgrades For Visteon Corp (NASDAQ:VC), Exane BNP Paribas upgraded the previous rating of Neutral to Outperform. For the first quarter, Visteon had an EPS of $1.09, compared to year-ago quarter EPS of
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB) gained 82.4% to $0.9819 after the company anno
We're seeing a bullish indicator -- another insider shopping spree. That means we could be in for another big short-term rally in the market.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE